Kathryn Arnold’s practice focuses on representing
pharmaceutical, biotechnology, and medical device companies in government and internal investigations.
Ms. Arnold has extensive experience representing life sciences companies in government investigations involving alleged violations of the Food, Drug and Cosmetic Act, the Anti-Kickback Statute, the False Claims Act, and other federal statutes, as well as in defending related False Claims Act litigation in federal courts across the country. With deep experience in the industry, Ms. Arnold also advises clients on a broad range of health care compliance issues including fraud and abuse, advertising and promotion, interactions with health care professionals, research/manufacturing, and compliance with the Anti-Kickback Statute. She also conducts internal corporate investigations, as well as advises clients on related remediation. Ms. Arnold has significant experience with e-discovery, and regularly counsels clients on complex issues, cost containment, and implementation of document management and other policies to minimize litigation risks.